Clinical Trial Update: Diamel in the Treatment of Metabolic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Diamel for metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Diamel

Snippet

Sponsor: Catalysis SL | Conditions: Metabolic Syndrome | Phase 3 | Status: COMPLETED